ELTROMBOPAG 12.5 mg/1

Eltrombopag 12.5 mg tablets are a medication used to support platelet production. This oral treatment is designed to help manage low platelet counts in specific conditions.

Eltrombopag is primarily used to increase platelet counts in adults with chronic immune thrombocytopenia (ITP) who have had an insufficient response to other treatments. It may also be used in certain other conditions where low platelet counts are a concern. Eltrombopag works by stimulating the production of platelets in the bone marrow, helping to maintain healthy levels.

Common effects of Eltrombopag may include fatigue, nausea, and dizziness. Some users may experience changes in liver function, so regular monitoring is advised. Always consult a healthcare provider for personalized advice.

Eltrombopag should be used with caution in patients with liver problems. It is important to follow the prescribed dosage and to inform your healthcare provider about any other medications you are taking. Regular blood tests may be required to monitor platelet levels and liver function.

Eltrombopag may interact with certain medications, including antacids, calcium supplements, and some antibiotics. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should be moderated while using this medication.